Several clinical and individual factors should inform decisions about GLP-1 treatment duration
Dosing is adjusted throughout your program based on your response and progress
Receptor density in cardiovascular and immune tissues is, however, markedly lower than in the pancreas, and the modest physiological increment in GLP-1 produced by DPP-4 inhibition does not appear sufficient to drive the downstream signaling needed for anti-inflammatory, endothelial, or plaque-modifying effects [13], [14], [28]
Ready to take control of your weight and health
Peripheral arterial disease , more prevalent in people with diabetes, can cause exertional calf pain (claudication), cold feet, absent pulses, and delayed healing
Neuroimmune mechanisms of opioid use disorder and recovery: translatability to human studies, and future research directions